肌少性肥胖与日本社区老年人残疾风险:5年纵向研究
该纵向队列研究纳入4197名日本社区老年人(平均年龄74.6±5.0岁,54.2%女性),采用AWGS 2019标准定义肌少症,体脂百分比≥25%或内脏脂肪≥100 cm2定义肥胖,随访5年观察长期护理保险认证的残疾发生。以非肌少症/非肥胖组为参照,肌少性肥胖组残疾风险HR 2.48(95%CI 2.24‒2.75,P<.001),高于单纯肌少症组(HR 2.09)。
要点
- 肌少性肥胖组残疾风险HR 2.48(95%CI 2.24‒2.75,P<.001),高于单纯肌少症组HR 2.09。
- 可能肌少症/肥胖组HR 1.54(95%CI 1.46‒1.62,P<.001),可能肌少症/非肥胖组HR 1.38(95%CI 1.29‒1.47,P<.028)。
- 社区老年人应评估肌少症与肥胖共存以筛查残疾发生风险。
核心结论
- 在日本社区老年人中,肌少性肥胖导致的残疾发生风险远高于单纯肌少症。
研究设计与样本
- 纵向队列研究,纳入4197名日本老年人(平均年龄74.6±5.0岁,54.2%女性)。
- 肌少症采用亚洲肌少症工作组2019算法识别,肥胖定义为体脂百分比≥25%或内脏脂肪含量≥100 cm2(男女相同)。
- 残疾发生定义为基线后5年内新发长期护理保险系统认证,缺失值采用多重插补处理。
- 采用Cox比例风险回归分析,以残疾发生为因变量,组别为解释变量,并调整潜在混杂因素。
主要发现
- 以非肌少症/非肥胖组为参照,可能肌少症/非肥胖组HR 1.38(95%CI 1.29‒1.47,P<.028)。
- 可能肌少症/肥胖组HR 1.54(95%CI 1.46‒1.62,P<.001)。
- 肌少症/非肥胖组HR 2.09(95%CI 1.96‒2.23,P<.001)。
- 肌少性肥胖组HR 2.48(95%CI 2.24‒2.75,P<.001)。
关键数值与推荐
- 肌少症识别采用亚洲肌少症工作组2019算法。
- 肥胖判定:体脂百分比≥25%或内脏脂肪含量≥100 cm2(男女相同)。
- 残疾发生定义:基线后5年内新发长期护理保险系统认证。
临床怎么用
- 卫生服务提供者应考虑评估肌少症与肥胖的共存,以筛查社区老年人的残疾发生风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Previous studies have indicated that sarcopenic obesity is a risk factor for disability onset. However, these studies had disparities in terms of criteria for sarcopenia, study design, or study population. No longitudinal study has investigated the effect of sarcopenic obesity on disability onset in an Asian population using the Asian Working Group for Sarcopenia 2019 criteria for sarcopenia definition. Herein, we aimed to investigate the longitudinal effect of sarcopenic obesity on disability onset in Japanese older adults and extend the generalizability of results to other populations. DESIGN: Longitudinal cohort study. SETTING AND PARTICIPANTS: A total of 4197 Japanese older adults (mean age 74.6 ± 5.0 years, 54.2% women) formed our study population. MEASUREMENTS: Sarcopenia was identified using the Asian Working Group for Sarcopenia 2019 algorithm. Obesity was determined when body fat percentage was ≥25%, or when visceral fat content was ≥100 cm2 for either sex. Disability onset was defined as a new case of long-term care insurance system certification for 5 years from baseline. Missing values were managed with multi-imputation. Cox proportional hazard regression analysis was used with disability onset as dependent variable and group (nonsarcopenia/nonobesity as a reference, nonsarcopenia/obesity, sarcopenia/non-obesity, possible sarcopenia/obesity, possible sarcopenia/non-obesity, sarcopenic obesity) as explanatory variable, and was adjusted for potential confounding factors. RESULTS: When the nonsarcopenia/nonobesity group was used as the reference category, other groups such as possible-sarcopenia/nonobesity [hazard ratio (HR) 1.38, 95% confidential interval (95% CI) 1.29‒1.47, P < .028], possible-sarcopenia/obesity (HR 1.54, 95% CI 1.46‒1.62 P < .001), sarcopenia/nonobesity (HR 2.09, 95% CI 1.96‒2.23, P < .001), and sarcopenic obesity (HR 2.48, 95% CI 2.24‒2.75, P < .001) showed significantly increased HRs. CONCLUSIONS AND IMPLICATIONS: The risk of disability onset because of sarcopenic obesity was exceedingly higher compared with sarcopenia alone among community-dwelling older adults in Japan The health providers should consider assessing the co-existence of sarcopenia and obesity to screen for the risk of disability onset in the community-dwelling population.
引用
- Morikawa M, Lee S, Makino K, et al. Sarcopenic Obesity and Risk of Disability in Community-Dwelling Japanese Older Adults: A 5-Year Longitudinal Study. J Am Med Dir Assoc. 2023. PMID: 37062369. doi:10.1016/j.jamda.2023.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。